中核结合因子的二次突变和细胞遗传改变 - 急性髓性白血病 (CBF-AML):系统性审查和元分析
Amin Javidan1, Alireza Azarboo1, Sayeh Jalali1
1School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Critical reviews in oncology/hematology
|May 24, 2025
概括
核心结合因子急性髓性白血病 (CBF-AML) 的二次遗传变化显著影响患者的存活率. 在c-KIT和FLT3-ITD的突变,以及三症8,与较差的结果有关,强调在治疗决策中需要基因分析.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 核心结合因子急性髓性白血病 (CBF-AML) 的预后一般是有利的.
- 然而,很大一部分患者复发,这表明其他遗传因素影响了结果.
- 研究二次细胞遗传异常和基因突变对于理解CBF-AML复发至关重要.
研究的目的:
- 评估二次细胞遗传异常和基因突变在CBF-AML的预后影响.
- 确定与CBF-AML患者的生存结果相关的遗传标记.
主要方法:
- 一个系统的文献综述和研究的元分析发表到2024年4月.
- 搜索的数据库包括PubMed,Embase,科学网络和Scopus.
- 数据提取和统计分析使用R.中的"元数据"包进行.
主要成果:
- 分析包括了59项研究.
- 在c-KIT和FLT3-ITD中的突变与总生存率 (OS) 和无病生存率 (DFS) 的下降显著相关.
- 三形8对预后产生了负面影响,而三形22与5年无复发存活率 (RFS) 的增加有关. N-RAS突变显示出一个可变的影响.
结论:
- 二次遗传变化,特别是c-KIT和FLT3-ITD突变和三症组8,与CBF-AML的生存率较低有关.
- 基因分析对于CBF-AML的风险分层和个性化治疗有价值.
- 进一步的研究应专注于针对高风险CBF-AML亚组的向治疗,以改善患者的治疗结果.
相关概念视频
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K
Mutations in Microorganisms
96
Mutations are heritable changes in an organism’s genome involving alterations in the base sequence of DNA or RNA. These changes can influence cellular processes and phenotypic traits, potentially transforming the unaltered wild type into a mutant form. Such changes, termed forward mutations, are pivotal in shaping the genetic diversity of organisms.RNA viruses exhibit the highest mutation rates due to the absence of robust proofreading mechanisms during genome replication. In contrast,...
96
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
13.1K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.1K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Spontaneous and Induced Mutations
191
Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).
191


